{"id":176317,"date":"2021-02-01T00:00:00","date_gmt":"2021-01-31T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/covid-19-autorisation-de-mise-sur-le-marche-conditionnelle-pour-un-troisieme-vaccin-covid-19-vaccine-astra-zeneca\/"},"modified":"2026-04-02T19:10:28","modified_gmt":"2026-04-02T17:10:28","slug":"covid-19-autorisation-de-mise-sur-le-marche-conditionnelle-pour-un-troisieme-vaccin-covid-19-vaccine-astra-zeneca","status":"publish","type":"post","link":"https:\/\/cbip.be\/fr\/covid-19-autorisation-de-mise-sur-le-marche-conditionnelle-pour-un-troisieme-vaccin-covid-19-vaccine-astra-zeneca\/","title":{"rendered":"COVID-19: autorisation de mise sur le march\u00e9 conditionnelle pour un troisi\u00e8me vaccin (COVID-19 Vaccine Astra Zeneca\u00ae)"},"content":{"rendered":"<p>Apr\u00e8s un avis favorable de l&#39;Agence europ\u00e9enne des m\u00e9dicaments (EMA)&#x002C; la Commission europ\u00e9enne a accord\u00e9 le 29 janvier 2021 une \u00ab\u00a0<strong>autorisation de mise sur le march\u00e9 conditionnelle<\/strong>\u00a0\u00bb (<em>conditional marketing authorisation<\/em>) \u00e0 un troisi\u00e8me\u00a0vaccin COVID-19\u00a0: le <strong>COVID-19 Vaccine Astra Zeneca\u00ae&#x002C; <\/strong><a href='https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu'><strong>voir site Web de l&#39;EMA<\/strong><\/a> (communiqu\u00e9 du 29\/01\/21).<br \/> Pour obtenir le \u00ab\u00a0<strong><em>Product Information<\/em><\/strong>\u00a0\u00bb <strong>(RCP et notice pour le public en anglais)<\/strong> du COVID-19 Vaccine Astra Zeneca\u00ae&#x002C; cliquez <a href='https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdf'><strong>ici<\/strong><\/a>.<\/p>\n<p>Le COVID-19 Vaccine Astra Zeneca\u00ae contient un ad\u00e9novirus de chimpanz\u00e9 non r\u00e9plicatif dans lequel a \u00e9t\u00e9 integr\u00e9e la s\u00e9quence g\u00e9n\u00e9tique codant la prot\u00e9ine Spike du virus.\u00a0Dans les <a href='https:\/\/www.cbip.be\/fr\/articles\/3518?folia=3503'><strong>Folia de janvier 2021<\/strong><\/a> &#x002C; vous trouverez une analyse des r\u00e9sultats interm\u00e9diaires de l&#39;\u00e9tude contr\u00f4l\u00e9e randomis\u00e9e&#x002C; avec crit\u00e8res d&#39;\u00e9valuation cliniques (\u00e9tude de phase II\/III)&#x002C; publi\u00e9e dans <strong><em>The Lancet<\/em><\/strong>. Il n&#39;y a pas eu de nouvelles publications depuis. Comme indiqu\u00e9 dans les <a href='https:\/\/www.cbip.be\/fr\/articles\/3518?folia=3503'>Folia de janvier 2021<\/a>&#x002C; un certain nombre de questions restent encore sans r\u00e9ponse et ce vaccin est tr\u00e8s peu document\u00e9 chez les personnes de plus de 55 ans.<br \/> Plus de d\u00e9tails sur le COVID-19 Vaccine Astra Zeneca\u00ae suivront dans les \u00ab\u00a0Informations r\u00e9centes\u00a0\u00bb de f\u00e9vrier 2021.<br \/> \u00a0<br \/> <strong>Trois vaccins COVID-19 ont maintenant re\u00e7u une autorisation de mise sur le march\u00e9 conditionnelle de l&#39;EMA<\/strong> : le COVID-19 Vaccine Astra Zeneca\u00ae&#x002C; et les vaccins \u00e0 ARNm Comirnaty\u00ae et COVID-19 Vaccine Moderna\u00ae [<a href='https:\/\/www.cbip.be\/fr\/chapters\/13?frag=8901332'>voir R\u00e9pertoire&#x002C; chapitre 12.1.1.15.<\/a>].<br \/> \u00a0<br \/> <strong>Note<\/strong>:<\/p>\n<ul>\n<li>\n<p>Pour tous nos articles relatifs aux m\u00e9dicaments dans la COVID-19: voir <a href='https:\/\/www.cbip.be\/fr\/gows\/3334'>Actualit\u00e9s COVID-19<\/a> sur notre site Web.\u00a0<\/p>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Apr\u00e8s un avis favorable de l&#39;Agence europ\u00e9enne des m\u00e9dicaments (EMA)&#x002C;  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,31],"tags":[20213,20224],"class_list":["post-176317","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2021-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=176317"}],"version-history":[{"count":1,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176317\/revisions"}],"predecessor-version":[{"id":178896,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176317\/revisions\/178896"}],"wp:attachment":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=176317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=176317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=176317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}